Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

The clonal evolution of tumor cell populations.

Nowell PC.

Science. 1976 Oct 1;194(4260):23-8.

PMID:
959840
2.

Cytogenetic abnormalities in cancer: with special emphasis on tumor heterogeneity.

Pathak S.

Cancer Metastasis Rev. 1990 Feb;8(4):299-318. Review.

PMID:
2182210
3.

Aneuploidy, the somatic mutation that makes cancer a species of its own.

Duesberg P, Rasnick D.

Cell Motil Cytoskeleton. 2000 Oct;47(2):81-107. Review.

PMID:
11013390
4.

Many different tumor types have polyclonal tumor origin: evidence and implications.

Parsons BL.

Mutat Res. 2008 Sep-Oct;659(3):232-47. doi: 10.1016/j.mrrev.2008.05.004. Review.

PMID:
18614394
5.

Stochastic cancer progression driven by non-clonal chromosome aberrations.

Heng HH, Stevens JB, Liu G, Bremer SW, Ye KJ, Reddy PV, Wu GS, Wang YA, Tainsky MA, Ye CJ.

J Cell Physiol. 2006 Aug;208(2):461-72.

PMID:
16688757
6.

Cytogenetic heterogeneity: its role in tumor evolution.

Wolman SR.

Cancer Genet Cytogenet. 1986 Jan 1;19(1-2):129-40.

PMID:
3455660
7.

The role of individual susceptibility in cancer burden related to environmental exposure.

Bartsch H, Hietanen E.

Environ Health Perspect. 1996 May;104 Suppl 3:569-77. Review.

9.

On the karyotypic origin and evolution of cancer cells.

Nicholson JM, Duesberg P.

Cancer Genet Cytogenet. 2009 Oct 15;194(2):96-110. doi: 10.1016/j.cancergencyto.2009.06.008.

PMID:
19781442
10.

The molecular biology of cancer.

Bertram JS.

Mol Aspects Med. 2000 Dec;21(6):167-223. Review.

PMID:
11173079
11.

An experimental model for oncogene activation during tumor progression in vivo.

Garte SJ, Burns FJ, Ashkenazi-Kimmel T, Cosma GN, Sawey MJ.

Anticancer Res. 1989 Sep-Oct;9(5):1439-46. Review.

PMID:
2686538
12.

Application of information theory and extreme physical information to carcinogenesis.

Gatenby RA, Frieden BR.

Cancer Res. 2002 Jul 1;62(13):3675-84.

13.

How aneuploidy may cause cancer and genetic instability.

Duesberg P, Rasnick D, Li R, Winters L, Rausch C, Hehlmann R.

Anticancer Res. 1999 Nov-Dec;19(6A):4887-906. Review.

PMID:
10697602
14.

Generation of phenotypic diversity and progression in metastatic tumor cells.

Nicolson GL.

Cancer Metastasis Rev. 1984;3(1):25-42. Review.

PMID:
6370418
15.

The cellular basis of tumor progression.

Heppner GH, Miller FR.

Int Rev Cytol. 1998;177:1-56. Review.

PMID:
9378615
16.

Mechanisms of multistep carcinogenesis and carcinogen risk assessment.

Barrett JC.

Environ Health Perspect. 1993 Apr;100:9-20. Review.

17.

Cancer-causing karyotypes: chromosomal equilibria between destabilizing aneuploidy and stabilizing selection for oncogenic function.

Li L, McCormack AA, Nicholson JM, Fabarius A, Hehlmann R, Sachs RK, Duesberg PH.

Cancer Genet Cytogenet. 2009 Jan 1;188(1):1-25. doi: 10.1016/j.cancergencyto.2008.08.016.

PMID:
19061776
18.

Transposable elements--is there a link between evolution and cancer?

Hauptmann S, Schmitt WD.

Med Hypotheses. 2006;66(3):580-91.

PMID:
16239072
20.

The rat Nb2 lymphoma: a novel model for tumor progression.

Gout PW, Horsman DE, Fox K, De Jong G, Ma S, Bruchovsky N.

Anticancer Res. 1994 Nov-Dec;14(6B):2485-92.

PMID:
7872671

Supplemental Content

Support Center